BIOMAT Database Logo BIOMAT Database Logo

Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreading-type and penetrating-type gastric carcinoma. 2001

K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
Department of Surgery, Kurume University School of Medicine, Kurume 830-0011, Japan.

The expression of epidermal growth factor (EGF), epidermal growth factor receptor (EGFR), transforming growth factor alpha (TGF alpha), and of c-erbB-2 was immunohistochemically investigated in resected gastric carcinoma (in 39 cases of superspreading type and in 11 cases of penetrating type), to understand the differential biological features of these two types of gastric carcinoma. EGF, EGFR and c-erbB-2 positive cases were preferentially found in penetrating type rather than in superspreading type (p < 0.05, p < 0.01, and p < 0.05, respectively). The positive rates of EGFR and c-erbB-2 were significantly higher in submucosal gastric carcinoma than in intramucosal gastric carcinoma (p < 0.01, p < 0.05, respectively). These results suggested that the autocrine mechanism of the growth factors and the expression of c-erbB-2 were correlated to the degree of gastric wall invasion.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D016211 Transforming Growth Factor alpha An EPIDERMAL GROWTH FACTOR related protein that is found in a variety of tissues including EPITHELIUM, and maternal DECIDUA. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form which binds to the EGF RECEPTOR. Epidermal Growth Factor-Related Transforming Growth Factor,TGF-alpha,TGFalpha,Epidermal Growth Factor Related Transforming Growth Factor

Related Publications

K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
January 1998, Anticancer research,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer.
January 1993, Pathobiology : journal of immunopathology, molecular and cellular biology,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
[HER2 (human epidermal growth factor receptor type 2), EGFR (epidermal growth factor receptor)].
November 2012, Nihon rinsho. Japanese journal of clinical medicine,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
[Immunohistochemical study of the coexpression of epidermal growth factor receptor (EGFR) and c-erbB-2 protein in colorectal cancer].
November 1993, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
c-erbB-2 oncoprotein and epidermal growth factor receptor in cervical lesions.
January 1997, Pathobiology : journal of immunopathology, molecular and cellular biology,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
Immunolocalization of epidermal growth factor receptor and c-erbB-2 oncogene product in human ovarian carcinoma.
October 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
March 1995, Cancer,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.
October 1994, Journal of clinical pathology,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
January 1996, European journal of gynaecological oncology,
K Aoyagi, and K Kohfuji, and S Yano, and N Murakami, and M Miyagi, and J Takeda, and K Shirouzu
Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.
January 2003, The International journal of biological markers,
Copied contents to your clipboard!